If people still remember what happened 4 years ago..
For the past 5 years,
Regeneron has outperformed its $IBB peers (except for Moderna, which is an outlier) by a wide margin.
Eli Lilly has outperformed its $PPH peers by a wide margin.
The two companies are now ranked the No.1 weight in $IBB and $PPH respectively.
